Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.930
-0.160 (-7.66%)
At close: Dec 27, 2024, 4:00 PM
1.910
-0.020 (-1.04%)
After-hours: Dec 27, 2024, 7:11 PM EST
Phio Pharmaceuticals Employees
As of December 31, 2023, Phio Pharmaceuticals had 9 total employees, including 8 full-time and 1 part-time employees. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
n/a
Profits / Employee
-$824,333
Market Cap
2.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
PHIO News
- 6 days ago - Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 9 days ago - Phio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 10 days ago - Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762 - Newsfile Corp
- 17 days ago - Phio Pharmaceuticals Announces Publication in Frontiers in Immunology - Newsfile Corp
- 19 days ago - Phio Pharmaceuticals is a Finalist for the Technology Disruptor of the Year Award - Newsfile Corp
- 26 days ago - Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study - Newsfile Corp
- 6 weeks ago - Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - Newsfile Corp